Catalysts and methods for ring opening metathesis polymerization

US9932440B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9932440-B2
Application numberUS-201715452505-A
CountryUS
Kind codeB2
Filing dateMar 7, 2017
Priority dateFeb 21, 2014
Publication dateApr 3, 2018
Grant dateApr 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention, among other things, provides highly syndiotactic poly(dicyclopentadiene) and/or hydrogenated poly(dicyclopentadiene), compositions thereof, and compounds and methods for preparing the same. In some embodiments, a provided compound is a compound of formula I, II or III. In some embodiments, a provided method comprises providing a compound of formula I, II or III.

First claim

Opening claim text (preview).

The invention claimed is: 1. A poly(dicyclopentadiene) polymer, wherein the polymer is greater than 95% syndiotactic as determined by 13 C NMR. 2. The polymer of claim 1 , wherein double bonds in the polymer backbone is greater than 90% cis as determined by 13 C NMR. 3. The polymer of claim 1 , wherein double bonds in the polymer backbone is greater than 95% cis as determined by 13 C NMR. 4. The polymer of claim 1 , wherein M n of the polymer is greater than about 5,000. 5. A composition comprising: the polymer of claim 1 , and a tungsten-containing compound. 6. The composition of claim 5 , wherein the tungsten-containing compound is a compound of formula I: wherein: R 1 is —C(R 1a ) 3 ; each R 1a is independently an optionally substituted group selected from C 1-10 aliphatic, C 1-10 heteroalkyl having 1-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic or polycyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen or sulfur, a 3-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen or sulfur; or: two R 1a groups are optionally taken together with the carbon atom to which they are attached to form an optionally substituted 3-10 membered, monocyclic, bicyclic or polycyclic, saturated or partially unsaturated ring having 0-4 heteroatoms independently selected from nitrogen, oxygen or sulfur; or: three R 1a groups are optionally taken together with the carbon atom to which they are attached to form an optionally substituted 4-10 membered, bicyclic or polycyclic, saturated or partially unsaturated ring having 0-4 heteroatoms independently selected from nitrogen, oxygen or sulfur; each of R 2 and R 3 is independently —R, —OR, —SR, —N(R) 2 , —OC(O)R, —S(O)R, —SO 2 R, —SO 2 N(R) 2 , —C(O)N(R) 2 , —NRC(O)R, or —NRSO 2 R; or: R 2 and R 3 are optionally taken together with the carbon atom to which they are attached to form an optionally substituted 3-10 membered, monocyclic, bicyclic or polycyclic, saturated or partially unsaturated ring having 0-4 heteroatoms independently selected from nitrogen, oxygen or sulfur; each R is independently hydrogen or an optionally substituted group selected from C 1-10 aliphatic, C 1-10 heteroalkyl having 1-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, a 6-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen or sulfur, a 3-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen or sulfur; or: two R groups are optionally taken together with the intervening atoms to form an optionally substituted 3-10 membered, monocyclic or bicyclic, saturated, partially unsaturated, or aryl ring having, in addition to the intervening atoms, 0-4 heteroatoms independently selected from nitrogen, oxygen or sulfur; R 4 is optionally substituted 5-14 membered heteroaryl having 1-4 heteroatoms independently selected from nitrogen, oxygen or sulfur, wherein at least one heteroatom is nitrogen; R 5 is —OAr a ; and Ar a is optionally substituted 7. The composition of claim 6 , wherein each R 1a is optionally substituted C 1-6 aliphatic or phenyl. 8. The composition of claim 6 , wherein R 1 is 9. The composition of claim 5 , wherein the tungsten-containing compound is a compound of formula II: wherein: each of R 2 and R 3 is independently —R, —OR, —SR, —N(R) 2 , —OC(O)R, —S(O)R, —SO 2 R, —SO 2 N(R) 2 , —C(O)N(R) 2 , —NRC(O)R, or —NRSO 2 R; or: R 2 and R 3 are optionally taken together with the carbon atom to which they are attached to form an optionally substituted 3-10 membered, monocyclic, bicyclic or polycyclic, saturated or partially unsaturated ring having 0-4 heteroatoms independently selected from nitrogen, oxygen or sulfur; each R is independently hydrogen or an optionally substituted group selected from C 1-10 aliphatic, C 1-10 heteroalkyl having 1-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, a 6-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen or sulfur, a 3-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen or sulfur; or: two R groups are optionally taken together with the intervening atoms to form an optionally substituted 3-10 membered, monocyclic or bicyclic, saturated, partially unsaturated, or aryl ring having, in addition to the intervening atoms, 0-4 heteroatoms independently selected from nitrogen, oxygen or sulfur; R 4 is optionally substituted 5-14 membered heteroaryl having 1-4 heteroatoms independently selected from nitrogen, oxygen or sulfur, wherein at least one heteroatom is nitrogen; R 5 is —OAr a ; Ar a is optionally substituted n is 0-2; and each R8 is independently a phosphorus-containing ligand, wherein the phosphorus-containing ligand is bonded to W through a phosphorus atom. 10. The composition of claim 9 , wherein the compound of formula II has the structure of formula II-a: wherein: R 4 is optionally substituted 5-14 membered heteroaryl having 1-4 heteroatoms independently selected from nitrogen, oxygen or sulfur, wherein at least one heteroatom is nitrogen; R 5 is —OAr a ; Ar a is optionally substituted each R 6 is independently —R, —OR, —SR, —N(R) 2 , —OC(O)R, —S(O)R, —SO 2 R, —SO 2 N(R) 2 , —C(O)N(R) 2 , —NRC(O)R, or —NR

Assignees

Inventors

Classifications

  • Carbenes or carbynes, i.e.(image) · CPC title

  • Compounds containing elements of Groups 6 or 16 of the Periodic Table · CPC title

  • derived from other polycyclic systems · CPC title

  • Ring opening metathesis polymerisation [ROMP] · CPC title

  • C08G61/08Primary

    of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9932440B2 cover?
The present invention, among other things, provides highly syndiotactic poly(dicyclopentadiene) and/or hydrogenated poly(dicyclopentadiene), compositions thereof, and compounds and methods for preparing the same. In some embodiments, a provided compound is a compound of formula I, II or III. In some embodiments, a provided method comprises providing a compound of formula I, II or III.
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification C08G61/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).